This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $11,827.51, is a Delivery Order for the 360 mg/2.4 ml on-body medication Skyrizi. The contract has a firm fixed price pricing type and an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,604.63 firm fixed-price delivery order is for the supply of Skyrizi 360 mg/2.4 ml on-body 2.4 ml medication, with a completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,121.07 firm fixed-price delivery order is for the supply of Skyrizi 150 mg/ml syringes. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm fixed-price delivery order is for the supply of the specialty medication SKYRIZI 150 MG/ML PENML. The contract has an ultimate completion date of August 5, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,604.63 Firm Fixed Price Delivery Order contract is for the supply of the prescription medication Skyrizi (360 mg/2.4 ml on-body 2.4 ml). The contract has an ultimate completion date of April 29, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,701.39 Firm Fixed Price delivery order is for the supply of Skyrizi 150 mg/ml injectable medication. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,209.26, is a delivery order for the supply of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty medication. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,744.99 firm fixed-price delivery order is for the medication Skyrizi 150 mg/ml, with a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $11,827.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Skyrizi 360 mg/2.4 ml on-body 2.4 ml. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Skyrizi 150 mg/ml pen injectors. The Firm Fixed Price delivery order, valued at $23,655.02, has an ultimate completion date of October 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...